Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 27 results.
User Information
Export Records
  1. 1.   AI-driven drug repurposing and binding pose meta dynamics identifies novel targets for monkeypox virus
  2. Patel,Chiragkumar; Mall, Raghvendra; Bensmail, Halima
  3. Journal of Infection and Public Health. 2023, Mar 15; 16(5): 799-807.
  1. 2.   Suppressive oligodeoxynucleotides containing TTAGGG motifs Inhibit cGAS activation in human monocytes
  2. Steinhagen, Folkert; Zillinger, Thomas; Peukert, Konrad; Fox, Mario; Thudium, Marcus; Barchet, Winfried; Putensen, Christian; Klinman, Dennis; Latz, Eicke; Bode, Christian
  3. European journal of immunology. 2018, Apr; 48(4): 605-611.
  1. 3.   The "Connection" Between HIV Drug Resistance and RNase H
  2. Delviks-Frankenberry, K. A.; Nikolenko, G. N.; Pathak, V. K.
  3. Viruses-Basel. 2010, Jul; 2(7): 1476-1503.
  1. 4.   C-terminal Domain Modulates the Nucleic Acid Chaperone Activity of Human T-cell Leukemia Virus Type 1 Nucleocapsid Protein via an Electrostatic Mechanism
  2. Qualley, D. F.; Stewart-Maynard, K. M.; Wang, F.; Mitra, M.; Gorelick, R. J.; Rouzina, I.; Williams, M. C.; Musier-Forsyth, K.
  3. Journal of Biological Chemistry. 2010, Jan; 285(1): 295-307.
  1. 5.   Structure of HIV-1 Reverse Transcriptase with the Inhibitor beta-Thujaplicinol Bound at the RNase H Active Site
  2. Himmel, D. M.; Maegley, K. A.; Pauly, T. A.; Bauman, J. D.; Das, K.; Dharia, C.; Clark, A. D.; Ryan, K.; Hickey, M. J.; Love, R. A.; Hughes, S. H.; Bergqvist, S.; Arnold, E.
  3. Structure. 2009 17(12): 1625-1635.
  1. 6.   Identifying and Characterizing a Functional HIV-1 Reverse Transcriptase-binding Site on Integrase
  2. Wilkinson, T. A.; Januszyk, K.; Phillips, M. L.; Tekeste, S. S.; Zhang, M.; Miller, J. T.; Le Grice, S.; Clubb, R. T.; Chow, S. A.
  3. Journal of Biological Chemistry. 2009 284(12): 7931-7936.
  1. 7.   Mutations in human immunodeficiency virus type 1 RNase H primer grip enhance 3-Azido-3'-deoxythymidine resistance
  2. Delviks-Frankenberry, K. A.; Nikolenko, G. N.; Barr, R.; Pathak, V. K.
  3. Journal of Virology. 2007, Jul; 81(13): 6837-6845.
  1. 8.   Mutations in the U5 sequences adjacent to the primer binding site do not affect tRNA cleavage by Rous sarcoma virus RNase H but do cause aberrant integrations in vivo
  2. Oh, J.; Chang, K. W.; Hughes, S. H.
  3. Journal of Virology. 2006, JAN; 80(1): 451-459.
  1. 9.   Crystal structures for HIV-1 reverse transcriptase in complexes with three pyridinone derivatives: A new class of non-nucleoside inhibitors effective against a broad range of drug-resistant strains
  2. Himmel, D. M.; Das, K.; Clark, A. D.; Hughes, S. H.; Benjahad, A.; Oumouch, S.; Guillemont, J.; Coupa, S.; Poncelet, A.; Csoka, I.; Meyer, C.; Andries, K.; Nguyen, C. H.; Grierson, D. S.; Arnold, E.
  3. Journal of Medicinal Chemistry. 2005, DEC 1; 48(24): 7582-7591.
  1. 10.   Crystallography and the design of anti-AIDS drugs: Conformational flexibility and positional adaptability are important in the design of non-nucleoside HIV-1 reverse transcriptase inhibitors
  2. Das, K.; Lewi, P. J.; Hughes, S. H.; Arnold, E.
  3. Progress in Biophysics and Molecular Biology. 2005, JUN; 88(2): 209-231.
  1. 11.   Fixed conformation nucleoside analogs effectively inhibit excision-proficient HIV-1 reverse transcriptases
  2. Boyer, P. L.; Julias, J. G.; Marquez, V. E.; Hughes, S. H.
  3. Journal of Molecular Biology. 2005, JAN 21; 345(3): 441-450.
  1. 12.   Taking aim at a moving target: designing drugs to inhibit drug-resistant HIV-1 reverse transcriptases
  2. Sarafianos, S. G.; Das, K.; Hughes, S. H.; Arnold, E.
  3. Current Opinion in Structural Biology. 2004, DEC; 14(6): 716-730.
  1. 13.   Integration target site selection for retroviruses and transposable elements
  2. Wu, X.; Burgess, S. M.
  3. Cellular and Molecular Life Sciences. 2004, OCT; 61(19-20): 2588-2596.
  1. 14.   Infectious transmission and replication of human T-cell leukemia virus type 1
  2. Derse, D.; Heidecker, G.; Mitchell, M.; Hill, S.; Lloyd, P.; Princler, G.
  3. Frontiers in Bioscience. 2004, SEP 1; 9: 2495-2499.
  1. 15.   Nonnucleoside inhibitor binding affects the interactions of the fingers subdomain of human immunodeficiency virus type 1 reverse transcriptase with DNA
  2. Peletskaya, E. N.; Kogon, A. A.; Tuske, S.; Arnold, E.; Hughes, S. H.
  3. Journal of Virology. 2004 78(7): 3387-3397.
  1. 16.   Structures of HIV-1 RT-DNA complexes before and after incorporation of the anti-AIDS drug tenofovir
  2. Tuske, S.; Sarafianos, S. G.; Clark, A. D.; Ding, J. P.; Naeger, L. K.; White, K. L.; Miller, M. D.; Gibbs, C. S.; Boyer, P. L.; Clark, P.; Wang, G.; Gaffney, B. L.; Jones, R. A.; Jerina, D. M.; Hughes, S. H.; Arnold, E.
  3. Nature Structural & Molecular Biology. 2004 11(5): 469-474.
  1. 17.   Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome
  2. Yu, Q.; Konig, R.; Pillai, S.; Chiles, K.; Kearney, M.; Palmer, S.; Richman, D.; Coffin, J. M.; Landau, N. R.
  3. Nature Structural & Molecular Biology. 2004 11(5): 435-442.
  1. 18.   Mutation of the catalytic domain of the foamy virus reverse transcriptase leads to loss of processivity and infectivity
  2. Rinke, C. S.; Boyer, P. L.; Sullivan, M. D.; Hughes, S. H.; Linial, M. L.
  3. Journal of Virology. 2002 76(15): 7560-7570.
  1. 19.   Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA : DNA
  2. Sarafianos, S. G.; Das, K.; Tantillo, C.; Clark, A. D.; Ding, J.; Whitcomb, J. M.; Boyer, P. L.; Hughes, S. H.; Arnold, E.
  3. Embo Journal. 2001 20(6): 1449-1461.
  1. 20.   The Lys103Asn mutation of HIV-1 RT: A novel mechanism of drug resistance
  2. Hsiou, Y.; Ding, J. P.; Das, K.; Clark, A. D.; Boyer, P. L.; Lewi, P.; Janssen, P. A. J.; Kleim, J. P.; Rosner, M.; Hughes, S. H.; Arnold, E.
  3. Journal of Molecular Biology. 2001 309(2): 437-445.
  1. 21.   Cross-linking of the fingers subdomain of human immunodeficiency virus type 1 reverse transcriptase to template-primer
  2. Peletskaya, E. N.; Boyer, P. L.; Kogon, A. A.; Clark, P.; Kroth, H.; Sayer, J. M.; Jerina, D. M.; Hughes, S. H.
  3. Journal of Virology. 2001 75(19): 9435-9445.
  1. 22.   RNase H cleavage of the 5 ' end of the human immunodeficiency virus type 1 genome
  2. Gao, H. Q.; Sarafianos, S. G.; Arnold, E.; Hughes, S. H.
  3. Journal of Virology. 2001 75(23): 11874-11880.
  1. 23.   Selective excision of AZTMP by drug-resistant human immunodeficiency virus reverse transcriptase
  2. Boyer, P. L.; Sarafianos, S. G.; Arnold, E.; Hughes, S. H.
  3. Journal of Virology. 2001 75(10): 4832-4842.
  1. 24.   Development of an in vivo assay to identify structural determinants in murine leukemia virus reverse transcriptase important for fidelity
  2. Halvas, E. K.; Svarovskaia, E. S.; Pathak, V. K.
  3. Journal of Virology. 2000 74(1): 312-319.
  1. 25.   Lamivudine (3TC) resistance in HIV-1 reverse transcriptase involves steric hindrance with beta-branched amino acids
  2. Sarafianos, S. G.; Das, K.; Clark, A. D.; Ding, J. P.; Boyer, P. L.; Hughes, S. H.; Arnold, E.
  3. Proceedings of the National Academy of Sciences of the United States of America. 1999 96(18): 10027-10032.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel